| Literature DB >> 28360582 |
Elif Ilgaz Aydinlar1, Pınar Yalinay Dikmen1, Ayşe Sağduyu Kocaman1.
Abstract
Since botulinum toxin might have a therapeutic effect on pain, many studies investigating the efficiency of botulinum toxin in headache treatment have been done. The most satisfying results were achieved by botulinum toxin type A (BoNT/A) in the treatment of chronic migraine. In this paper, we reviewed the clinical effectiveness of BoNT/A in migraine and included our clinical experience. In our ongoing pilot study, where we have repeated BoNT/A injections every 12 weeks, The difference in the Migraine Disability Assessment (MIDAS) scores between the first and the second injections was 61.1%; and between the first and the 3rd injections was found to be 65.72%.Entities:
Keywords: Botulinum toxin; chronic migraine; headache
Year: 2013 PMID: 28360582 PMCID: PMC5353076 DOI: 10.4274/npa.y7198
Source DB: PubMed Journal: Noro Psikiyatr Ars ISSN: 1300-0667 Impact factor: 1.339